Businesses, Organizations, and Universities

Helping return to work and learning safely and confidently

Screening and Testing Programs

Labcorp is committed to supporting organizations,
businesses and universities get back to work and learning safely.

Labcorp, a leading provider of integrated workforce strategies including drug and alcohol testing, biometric screening, population health, and comprehensive vaccination programs, is helping employers and universities return to work and schools safely and confidently. Our flexible on-site and remote COVID-19 screening and testing options can be tailored to meet your organization's needs and are designed to support your overall population health, risk management, and employer return-to-work strategies. Powered by our extensive in-house network of personnel located throughout the country and our diagnostic testing capabilities of Labcorp, we can scale to meet your program needs.

COVID-19 Testing and Vaccinations

On September 9, 2021, President Joe Biden announced a series of steps to combat the COVID-19 pandemic, including a rule that would require companies with more than 100 employees to mandate vaccinations or weekly testing.

We can help employers remain compliant with government regulations through our diagnostic testing and screening capabilities and deliver the critical insight you need through deep, analytical reporting. Contact us to talk through a plan, tailored to your business strategy.

COVID-19 PCR Testing (Nasal Swab)

PCR testing is for individuals who may have an active COVID-19 infection. It can be performed at work or home for asymptomatic employees or students, with results available on average in 2-4 days.

On-site: Labcorp staff are on site to assist with sample collection, preparation, and shipment.

Off-site: Our At-home COVID-19 Test Collection Kit can be sent directly to employees at their home and is a self-administered nasal swab.

COVID-19 Antigen Point-of-Care Testing (Nasal Swab)

Antigen testing is for individuals who may have an active COVID-19 infection. It can be performed at work for asymptomatic employees or students, with results available in 15-20 minutes.

COVID-19 IgG Antibody Testing (Blood/Serology)

Antibody testing is for individuals who think they may have previously had COVID-19 and do not currently have symptoms. It can check for antibodies that may have developed after exposure to the virus that causes COVID-19. Results are available on average in 2-4 days.

On-site: This test is available as a dried blood spot finger stick test or as a blood draw, both of which can be performed conveniently at your facility.

Off-site: This blood draw test is performed by a phlebotomist at a Labcorp patient service center or Labcorp at Walgreens location, all of which are conveniently located across the U.S.

Employees with active COVID-19 symptoms should contact their doctor or healthcare provider. Antibody testing should not be used as the sole basis to diagnose or exclude infection.

COVID-19 Screening

Labcorp’s workforce strategy solutions assists organizations in identifying employees with elevated temperatures and other possible COVID-19 symptoms who are reporting to work during the COVID-19 pandemic.

Both services consist of a simple, two-step process managed by on-site trained staff:

  1. Completion of a questionnaire to screen for symptoms that may be consistent with COVID-19
  2. Performance of a no-contact temperature check

Employer PDF Resources

Thermal Temperature Check

Get Started

Call Labcorp Employer Services at 1-877-469-5411

Contact Form

To learn more about Labcorp Employer Services’ portfolio of workforce strategies and COVID-19 return to work and school services, complete the form below.

CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

References

https://www.whitehouse.gov/covidplan/

https://www.shrm.org/resourcesandtools/hr-topics/talent-acquisition/pages/federal-vaccine-mandate.aspx

Disclaimer:

Labcorp’s COVID-19 PCR test has not been FDA cleared or approved, has been authorized by the FDA under an Emergency Use Authorization (EUA), and has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Labcorp’s fingerstick, or dried blood spot, IgG antibody test is being provided as a laboratory developed test, and uses the Euroimmun platform which received Emergency Use Authorization by the U.S. Food and Drug Administration. Labcorp completed independent validation studies on this testing. The COVID-19 IgG antibody blood test detects the presence of antibodies to the virus and can help determine if an individual may have been exposed to the virus. While antibody tests are helpful to understand if an individual has developed antibodies and a potential immune response, antibody testing should not be used as the sole basis to diagnose or exclude infection.

COVID-19 Information and Resources

Scroll back to top of page